The cDNA coding for xanthine dehydrogenase (XD) is isolated from mouse liver mRNA by cross-hybridization with a DNA fragment of the Drosophila melanogaster homologue. Two A bacteriophage overlapping clones represent the copy of a 4538-nucleotide-residue-long transcript with an open reading frame of 4005 nucleotide residues, coding for a putative polypeptide of 1335 amino acid residues. Comparison of the deduced amino acid sequence of the mouse XD with those of the Drosophila and the rat homologues shows a high conservation of this protein (55 % identity between mouse and Drosophila, and 94 % identity between mouse and rat). RNA blotting analysis demonstrates that interferon-a (IFN-a) and its inducers, i.e. poly(I) -poly(C), bacterial lipopolysaccharide (LPS) and tilorone {2,7-bis-[2-(diethylamino)ethoxy]fluoren-9-one}, increase the expression of XD mRNA in liver. Poly(I) . poly(C) also induces XD mRNA in several other tissues in vivo. Protein synthesis de novo is not required for the elevation of XD mRNA after IFN-a treatment, since cycloheximide does not block the induction. The elevation of XD mRNA concentration is relatively fast and precedes the induction of both XD and xanthine oxidase (XO) enzymic activities.
INTRODUCTION
Xanthine oxidoreductase is the enzyme system that catalyses the oxidation of hypoxanthine to xanthine and subsequently to uric acid (Dixon & Webb, 1964) . The enzyme is a single-gene product and it exists in two separate but interconvertible forms, xanthine dehydrogenase (EC 1.1.1.204; XD) and xanthine oxidase (EC 1.1.3.22, formerly EC 1.2.3.2; XO). The former uses NADI as the acceptor of reducing equivalents whereas the latter transfers them to molecular 02-XD and XO enzymic activities are contemporaneously detected in a variety of tissues, even though the conversion of XD into XO makes the latter the most readily extractable form (Gilbert & Bergel, 1964; Krenitsky et al., 1986; Carpani et al., 1990) . In fact, XD is converted into XO in various experimental conditions in vitro (Della Corte & Stirpe, 1968 , 1972 . The conversion of XD into XO induced by oxidation is reversible after treatment with reducing agents, and partial proteolytic cleavage irreversibly transforms XD into XO (Granger et al., 1981; Engerson et al., 1987; Oda et al., 1989) . In vivo, it is known that XO is produced from XD in various pathological conditions, where it has been proposed to play an important pathogenetic role (Granger et al., 1981; Engerson et al., 1987; Reiners et al., 1987; Elsayed & Tierney, 1989) . In particular, this enzyme seems to be primarily responsible for the vascular injury associated with intestinal (Parks & Granger, 1983) , cardiac (McCord, 1985; Terada et al., 1991) and hepatic ischaemia (de Groot & Littauer, 1988; Brass et al., 1991) . The involvement of XO in tissue damage is probably related to the ability of this enzyme to produce highly reactive 0;-anions (Fridovich, 1970) .
XO seems to mediate some of the toxic effects produced by interferons (IFNs) and their inducers in the mouse (Renton et al., 1984; Ghezzi et al., 1984 Ghezzi et al., , 1985 Deloria et al., 1985) . In fact, recombinant IFNs as well as bacterial lipopolysaccharide (LPS) and poly(I) * poly(C) induce XO enzymic activity and depress cytochrome P-450 concentrations in mouse liver. This toxic effect is prevented by pretreatment of the animals with allopurinol and N-acetylcysteine, a specific inhibitor of XO and a scavenger of oxygen radicals respectively (Taylor et al., 1980; Roy & McCord, 1982; Ghezzi et al., 1985; Bindoli et al., 1988) .
To study the molecular mechanisms underlying the elevation of XO enzymic activity by IFNs and their inducers, the cDNA coding for XD was isolated from mouse liver mRNA. With the use of this cDNA clone as a probe, the elevation of XO/XD activity by IFN-a and its inducers is demonstrated to be mostly due to an increased accumulation of XD mRNA.
MATERIALS AND METHODS Animal treatments
CD-1 mice obtained from Charles River Italia (Calco, Como, Italy) weighing approx. 30 g were intraperitoneally treated with poly(I) * poly(C) (Sigma Chemical Co., St. Louis, MO, U.S.A.) (10 mg/kg body wt.), recombinant IFN-a (A/D) (IFN-a; 107 units/mg of protein) (Roche, Nutley, NJ, U.S.A.) (1.5 x 105 units/kg body wt.), LPS (Sigma Chemical Co.) (2 mg/kg body wt.), recombinant human interleukin-1l, (107 units/mg of protein) (Sclavo, Siena, Italy) (30 ,tg/kg body wt.) or recombinant human tumour necrosis factor-ac (107 units/mg of protein) (Cetus Corp., Emeryville, CA, U.S.A.) (30 ,ug/kg body wt.). IFN-a (A/D) is a human hybrid IFN-a was administered to the animals 2 h before the treatment with IFN or saline alone to study the effect of inhibition of protein synthesis on the induction of liver XD mRNA by IFN-a itself. Tilorone {2,7-bis-[2-(diethylamino)ethoxy]fluoren-9-one} (Merrel Dow Pharmaceutical, Cincinnati, OH, U.S.A.) (75 mg/kg body wt.) was administered orally. The effect of LPS on the induction of liver XD mRNA was also tested in two different mouse strains, C3H/HeJ (a strain resistant to the effect of LPS) and C3H/HeN (a strain with the same genetic background as C3H/HeJ, but sensitive to LPS) (Charles River) (O'Brien et al., 1982) .
Isolation of mouse liver XD cDNAs
In order to obtain molecular probes that could be used for the isolation of mouse XD cDNA, two stretches of the Drosophila melanogaster XD gene (Keith et al., 1987; Lee et al., 1987) , between nucleotide residues 1496-2018 and 3014-3643 respectively, were amplified according to the instructions of the manufacturer (Cetus Perkin-Elmer, Norwalk, CT, U.S.A.). Amplified fragments were subcloned in pBluescript SK (Stratagene) with standard techniques (Maniatis et al., 1982) and their identity was verified by seqencing.
The amplified oligo(dT)-primed mouse liver cDNA library in AgtlO was purchased from Clontech Laboratories (Palo Alto, CA, U.S.A.). The oligo(dT) and the randomly primed cDNA libraries inserted in the EcoRI site of AZAP II vector (Stratagene) were constructed with the use of liver polyadenylated RNA obtained from mice treated with 10 mg of poly(I) . poly(C)/ kg body wt. according to standard protocols (Huynh et al., 1985) . In all, 7 x 105 plaques from the commercial cDNA library were screened with the 32P-labelled Drosophila XD gene probes. The filters were hybridized at 53°C in a solution containing S x SSC, 5 x Denhardt's and 100 ,tg of salmon sperm DNA/ml (Maniatis et al., 1982) (XDgtl) .
To obtain the 3'-end of mouse XD cDNA, 50000 primary recombinant plaques derived from the oligo(dT)-primed poly(I) * poly(C)-induced liver cDNA library constructed in Azap II vector were screened with 32P-labelled XDgtl insert as a probe, in standard conditions (Maniatis et al., 1982) . Positive clones were isolated and the DNA inserts were recovered as subclones in pBluescript KS according to the instructions of the manufacturer (Stratagene). Only one clone (XDzap 12), containing the longer insert, was further characterized.
To obtain part of the 5'-end of XD cDNA, two anti-sense strand oligonucleotides (positions 1630-1654 and 1594-1623 in Fig. 2 ) were synthesized. The former was used to prepare a cDNA library in the EcoRI site of the plasmid pUC18 (Pharmacia, Uppsala, Sweden) by primer extension of polyadenylated RNA obtained from the liver of poly(I) -poly(C)-treated mice (Huynh et al., 1985) . Approx. 2000 bacterial colonies were screened with the latter oligonucleotide under the conditions described by Wood et al. (1985) . Four (Sanger et al., 1977) (Feinberg & Vogelstein, 1983 (w/v) . After centrifugation, the pellet was resuspended in 1 ml of 100 mM-potassium phosphate buffer, pH 7.8, containing I mM-EDTA and 1 mM-phenylmethanesulphonyl fluoride and dialysed overnight against 100 vol. of the same buffer.
The enzyme assay was performed in a Beckman DU-65 spectrophotometer at 25 'C (Stirpe & Della Corte, 1969 protein and time. One unit of enzyme activity is defined as I nmol of uric acid produced/min (Suleiman & Stevens, 1985) . The data were normalized for the content of proteins determined by the Bio-Rad kit (Bio-Rad Laboratories, Richmond, CA) with BSA as a standard (Sigma Chemical Co.) (Bradford, 1976) .
RESULTS AND DISCUSSION
Cloning and structure of the cDNA coding for mouse liver XD When the molecular cloning of the cDNA coding for mouse XD was started, no data on the primary structure of this enzyme in higher eukaryotes were available, except for that of Drosophila melanogaster, which was identified and isolated by genetic complementation of the Rosy locus (Bender et al., 1983; Keith et al., 1987; Lee et al., 1987) . XDgtl was thus isolated by cross-hybridization with the Drosophila melanogaster XD gene. Isolation of the other overlapping clones was as detailed in the Materials and methods section. The restriction map of the mouse XD cDNA as defined by the isolated overlapping clones is shown in Fig. 1 .
The total length of the mouse XD cDNA is 4538 nucleotide residues (Fig. 2) . The longest open reading frame deduced from the DNA sequence is 4005 nucleotide residues long, coding for a putative polypeptide of 1335 amino acid residues. This is consistent with the fact that the protein product of this gene has an approximate molecular mass of 150 kDa (Carpani et al., 1990) . The assignment of the first ATG codon is presumptive, owing to the lack of N-terminal sequence data of the protein. The contention, however, is supported by the protein and cDNA sequences of the rat (Amaya et al., 1990 ) and the Drosophila (Keith et al., 1987; Lee et al., 1987) XD. In these two animal species, the first methionine codon appears at a position similar to that of the mouse cDNA, and the three genes share great similarity in this region of the protein, as described below. The open reading frame of the mouse XD cDNA is followed by a 531-nucleotide-residue-long 3' untranslated region containing a polyadenylation signal, AATAAA (nucleotide residues 4518-4523 in Fig. 2 ) (Wickens & Stephenson, 1984; Birnstiel et al., 1985) that is located-10 nucleotide residues upstream of the poly(A) tail. The XD transcript is devoid of a nucleotide sequence coding for a hydrophobic signal peptide. This feature is consistent with the cytoplasmic localization of the XD protein.
Comparison of mouse XD protein with its rat and Drosophila homologues DNA sequence analysis of the mouse XD cDNA in its coding region demonstrates a high level of similarity with the Drosophila (57 %) (Keith et al., 1987) and the rat homologue (91 %) (Amaya et al., 1990) , resulting in a high degree of similarity in their protein products.
The comparison between the deduced primary structure of mouse XD protein and its rat and Drosophila homologues is presented in Fig. 3 . The overall similarity between mouse and Drosophila XD is 55 %, whereas it is 94 % between the mouse and the rat proteins. The similarity is even higher in their secondary structure, since the hydrophobicity plot is almost superimposable throughout the three animal species (results not shown). The mouse XD polypeptide is composed of 1335 amino acid residues and it has the same length as the Drosophila XD, but it is 16 amino acid residues longer than the rat counterpart. A stretch of the mouse sequence coding for 12 amino acid residues (amino acid residues 485-496 in Fig. 3 ) is found both in mouse and in Drosophila XD, but not in rat XD. This could represent a bona fide difference relative to the rat, especially in consideration of the fact that it was found in at least two independent clones (XDzap64 and XDpuca2). However, it is also possible that more than one mature XD mRNA transcripts are present both in the rat and in the mouse. A striking similarity among the three XD proteins is found at their N-terminal and Cterminal regions. The N-terminal sequence of the mouse XD is, however, 3 amino acid residues longer than the rat homologue, owing to the presence of a Thr-Arg-Thr tripeptide after the putative translation initiation codon for methionine. (Nishino & Nishino, 1989; Amaya et al., 1990) , and is presented with its deduced amino acid sequence (upper line). Amino acid residues are numbered from the N-terminus to the C-terminus starting from the putative first methionine residue, whereas nucleotide residues are numbered in the 5' to 3' direction. A putative NAD+-binding site (Nishino & Nishino, 1989; Amaya et al., 1990 ) is boxed, and two consensus sequences coding for Gly-Xaa-Gly-Xaa-Xaa-Gly, essential for NAD+ and FAD binding (Guest & Rice, 1984; Williams et al., 1984; Wierenga et al., 1985) , are underlined. The polyadenylation signal, AATAAA (Wickens & Stephenson, 1984; Birnstiel et al., 1985) , is doubly underlined. The deduced amino acid sequences of mouse (in), rat (r) and Drosophila melanogaster (d) XD are aligned. The rat sequence is derived from Amaya et al. (1990) and the Drosophila melanogaster sequence is from Keith et al. (1987) and Lee et at. (1987) . The amino acid residues are indicated by the one-letter code. Numbering starts from the first methionine residue. Identical amino acid residues in the rat and Drosophila sequences are indicated as dots except for the first methionine residue, and gaps introduced in the sequence to obtain the best alignment are indicated as bars. Cysteine residues are boxed. Consensus sequences, Gly-Xaa-Gly-Xaa-Xaa-Gly (where Xaa stands for any amino acid residue) for the binding sites of nucleotide cofactors, NAD' or FAD, are doubly overlined. The region corresponding to the binding site of NAD', as determined by comparison of the 5'-p-fluorosulphonylbenzoyladenosine-labelled peptide sequence of chicken XD (Nishino & Nishino, 1989) , is boxed by a dotted line.
difference in the environment at the NAD'-binding site may Wierenga et at., 1985) are well conserved in the three animal reflect the fact that, unlike in mammals, XD cannot be converted species, suggesting their functional relevance.
into XO in this in-sect. was extracted from mouse liver before and after treatment with IFN-a or poly(I) * poly(C). As shown in Fig. 4 , the XD transcript is barely detectable before the treatment, whereas after induction with either IFN-a or poly(I) poly(C) a strong signal, which migrates slightly faster than the 28 S rRNA, is observed. The kinetics of induction of XD mRNA in the mouse liver after treatment with poly(I) -poly(C) is relatively fast, since the accumulation of the transcript is already visible at 2 h and it attains its maximum level at 12 h (Fig. 5a) . At 24 h, the level of XD mRNA decreases towards the basal level. To study whether XD mRNA correlates with its translation into catalitically active XO and XD, the sum of the two enzyme activities (XO + XD) was measured. The induction of XD mRNA precedes the elevation of XO + XD enzyme activities (at 2 h, XO + XD activity is not significantly different from the basal level; Fig. 5b) . At 24 h, XD mRNA decreases dramatically whereas XO + XD activities are still at their plateau. At 48 h, XO + XD activities decrease to the same levels observed at 2 h (results not shown).
Considering that XO and XD have very similar Km and Vmax values for xanthine (Bindoli et al., 1985) and that the XD/XO ratio is not significantly changed after administration of poly(I) * poly(C) (for instance, the mean + S.E.M. iS 1.2 + 0.1 in control conditions compared with 1.1 + 0.2 after 24 h of poly(I) -poly(C) treatment, confirming the results reported by Ghezzi et al., 1984) , the reported increase in XO activity after treatment with poly(I) -poly(C) (Ghezzi et al., 1984 (Ghezzi et al., , 1985 is thus primarily the result of a dramatic increase in the steady-state concentrations of XD transcript. However, a remarkable difference between the maximal induction level of XD transcript (about 30-fold) and that of XO+XD enzyme activities (3-10-fold, according to the experiment) is always observed. It is thus possible that not all the transctibed XD mRNA is translated into protein.
To investigate whether other known inducers of IFN-a are also effective in inducing XD mRNA, bacterial LPS and tilorone were administered in vivo, and the elevation of the XD transcript was compared with that obtained by IFN-a and by poly(I) * poly(C). As shown in Fig. 6 (a) poly(I) * poly(C), LPS and tilorone are all capable of inducing XD gene expression, albeit with different potencies. Furthermore, cycloheximide (a known inhibitor of protein synthesis) does not affect the concentration of XD transcript induced by IFN-a, demonstrating that protein synthesis de novo is not required for this induction.
Since LPS is known to stimulate many other cytokines besides IFN-a in vivo, the specificity of the elevation of XD message by IFN-a was examined. Animals were treated with two cytokines known to be induced by LPS in vivo, i.e. tumour necrosis factor and interleukin-1. Fig. 6(b) demonstrates that neither interleukin-1 nor tumour necrosis factor is capable of inducing XD mRNA in conditions where poly(I) -poly(C) is effective. Furthermore, the induction by LPS is effective only in the LPS-sensitive mouse strain (C3H/HeN), whereas poly(I) * poly(C) induces XD mRNA accumulation regardless of the sensitivity of the mouse strain to LPS (Fig. 6c) .
The transcriptional activation of the XD gene by poly(I) -poly(C) was tested in various tissues. As shown in Fig. 7 , in basal conditions the concentration of XD mRNA is very low in all the tissues studied (the XD mRNA band is visible in liver and intestine only after longer exposures of the autoradiograms). The induction of XD transcript is observed not only in liver but in all other tissues tested so far. Except for spleen and brain, high Vol. 283 levels of accumulation of the XD mRNA after poly(I)-poly(C) treatment are detected in all the other tissues. This specific induction places XD among a few genes whose products have a known enzymic and functional activity that are responsive to IFN treatment in vivo (Staheli, 1990) . The kinetics of induction as well as the fact that protein synthesis de novo is not required for the induction is consistent with the hypothesis that this gene is a primary target of the programmed response of the mammalian cells to IFNs. It is yet to be established, however, whether increased XD gene expression is the result of a transcriptional phenomenon and whether the gene itself contains the consensus sequence known to be generally present in the genes that are responsive to treatment with IFNs (Levy et al., 1988) . The results presented in this study were obtained with type 1 recombinant IFN-ac, but induction of XD mRNA is also achieved by type II IFN (M. Terao, G. Cazzaniga, P. Ghezzi, M. Bianchi, F. Falciani, P. Perani & E. Garattini, unpublished work). Since type I and type II IFNs act through different receptors, it would be interesting to know whether induction of XD mRNA by the two types of IFNs requires the same or different intracellular signals.
The induction of XD transcript is not limited to the liver but is observed in all the tissues so far tested, suggesting that the induction of XD mRNA is independent of the cell context on which IFN is acting. However, the cell population(s) involved in XD mRNA induction in the various tissues is still unknown.
As to the role of the XD/XO system in the pathophysiological events triggered by treatments of the animals with IFNs in vivo, the involvement of XO in some of the toxic effects mediated by this cytokine are suggested by a series of reports (Ghezzi et al., 1984 (Ghezzi et al., , 1985 Mannering et al., 1988) . IFN-a depresses cytochrome P-450 and induces XO in the liver. The depression of cytochrome P-450 is inhibited by pretreatment of the animals with allopurinol (a specific inhibitor of XO and XD) and by oxygen-radical scavengers such as N-acetylcysteine (Ghezzi et al., 1985) . These data suggest XO and°2-anions derived from its activity as the mediators of this toxic effect. A key question is represented by the role of the XD/XO system in other biological effects produced by IFNs. It is possible that the increased concentration of XD mRNA is a secondary and incidental event resulting from an alteration in the intracellular purine pool, caused by IFNs. However, it is also possible that the increased production of superoxides derived from the XO system might be related to the antiproliferative or antiviral activity of IFNs. Cloning of the mouse XD cDNA along with the development of a suitable cellculture system should be extremely helpful in answering these questions.
